Literature DB >> 2214027

Heterogeneity and evolution rates of delta virus RNA sequences.

F Imazeki1, M Omata, M Ohto.   

Abstract

To investigate the geographical divergence of delta virus RNA sequences, 868 nucleotides (nt), including the delta antigen-coding region, were determined in isolates from two Japanese patients, M and S, by polymerase chain reaction and direct sequencing and compared with three previously reported nucleotide sequences. The sequence obtained for hepatitis delta virus RNA from patient M was approximately 92% identical to sequences previously obtained for two other strains of hepatitis delta virus, whereas the sequence of hepatitis delta virus RNA obtained from patient S was approximately 81% identical to the previously sequenced strains. This suggests that delta agent in Japan has a heterogeneous origin and the delta virus RNA sequence from Japanese patient S is the most divergent delta virus isolate yet analyzed. To study the evolution rate of delta virus RNA, viral isolates obtained 3 and 4 years apart from each of two patients were also sequenced. It was estimated that the substitution rate of viral RNA was 0.57 x 10(-3) nt per site per year in patient M and 0.64 x 10(-3) nt per site per year in patient S for the delta antigen gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2214027      PMCID: PMC248612     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene.

Authors:  D A Buonagurio; S Nakada; J D Parvin; M Krystal; P Palese; W M Fitch
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

2.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

Review 3.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

4.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.

Authors:  T Gojobori; S Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.

Authors:  M Tada; M Omata; M Ohto
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

7.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

8.  Delta hepatitis agent: structural and antigenic properties of the delta-associated particle.

Authors:  F Bonino; B Hoyer; J W Shih; M Rizzetto; R H Purcell; J L Gerin
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.

Authors:  A Ponzetto; P J Cote; H Popper; B H Hoyer; W T London; E C Ford; F Bonino; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.

Authors:  G M Air
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

View more
  27 in total

1.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture.

Authors:  Jinhong Chang; Severin O Gudima; John M Taylor
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Complete nucleotide sequence of hepatitis delta virus RNA in Japan.

Authors:  F Imazeki; M Omata; M Ohto
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

Review 4.  Life cycle and pathogenesis of hepatitis D virus: A review.

Authors:  Zaigham Abbas; Rafia Afzal
Journal:  World J Hepatol       Date:  2013-12-27

5.  Phylogenetic analysis of hepatitis D viruses indicating a new genotype I subgroup among African isolates.

Authors:  Y Y Zhang; E Tsega; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks.

Authors:  John L Casey; Bud C Tennant; John L Gerin
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Introduction of a new hepatitis agent in retrospect: genetic studies of Swedish hepatitis D virus strains.

Authors:  Y Y Zhang; B G Hansson
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

8.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 9.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.

Authors:  Hsuan Hui Shih; King-Song Jeng; Wan-Jr Syu; Yi-Hsiang Huang; Chien-Wei Su; Wei-Li Peng; I-Jane Sheen; Jaw-Ching Wu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.